Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-31

FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claravis (isotretinoin)

Snippet

SUPPL AP for CLARAVIS (ISOTRETINOIN)